Stratview Research has published a new report on the Heart Implants Market, segmented By Device (Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve, Others), By Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, Others), By End User (Hospitals, Emergency Medical Centers, Ambulatory Surgical Center, Home Care Settings, Others) and Region.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.
Market Highlights
The Heart Implants Market is estimated to grow from USD 36.8 billion in 2020 to USD 71.6 billion by 2026 at a healthy CAGR of 11.9% during the forecast period.
To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/2402/Heart-Implants-Market.html#form
Covid Impact
Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.
Segmentation –
This report studies the Heart Implants Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:
Based on application, the market has been classified into arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure, and others. The arrhythmias segment accounted for a substantial market share in 2020. Growing incidences of Cardiovascular Diseases (CVDs), increasing cost of cardiac disease management, favorable government policies; and excessive alcohol consumption, smoking, lifestyle disorders, and obesity are contributing to the prevalence of cardiac arrhythmia, further bolstering the segment growth.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, the strong prevalence of cardiovascular diseases, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, easy availability of advanced technology, and enhanced patient knowledge within the region, further proliferates the regional growth.
Following are the key players in the Heart Implants Market:
· Medtronic, Inc. (US)
· Boston Scientific Corporation (US)
· Abbott Vascular Inc. (US)
· Edwards Life-sciences Corporation (US)
· St. Jude Medical, Inc. (US)
· Thoratec Corporation (US)
· SynCardia Systems, Inc. (US)
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with our team here–
https://www.stratviewresearch.com/contact
Or
Call us @: +1-313-307-4176
Write a comment